Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Arno Therapeutics Inc.
DescriptionAnalog of AR-12, a small molecule 3-phosphoinositide dependent protein kinase-1 (PDPK1) inhibitor
Molecular Target 3-phosphoinositide dependent protein kinase-1 (PDPK1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat acute and chronic antibiotic-resistant bacterial infections in patients with cystic fibrosis (CF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today